Therapy News and Research

RSS

Fitness study shows exercise at work can cut chronic disease risks

Researchers evaluate the efficacy of this exercise-based workplace health promotion program at the University of L’Aqulia.

11 Sep 2025

Elinzanetant reduces hot flashes in menopause

The OASIS-3 trial demonstrates elinzanetant's effectiveness in alleviating menopausal symptoms, reducing hot flashes significantly over a year-long study.

11 Sep 2025

Antibody cocktail could change the way the world fights influenza

An unusual therapy developed at The Jackson Laboratory (JAX) could change the way the world fights influenza, one of the deadliest infectious diseases.

11 Sep 2025

Study highlights menopause-related vocal changes in women

A new University of South Florida study published in Menopause highlights a largely overlooked health issue: voice changes that many women experience during menopause, often triggered by falling levels of estrogen and progesterone.

10 Sep 2025

Targeting telomere damage offers new path to boost cancer immunotherapy

Tumors are stressful places for cancer-fighting immune cells. Low oxygen, high acid levels, and other stressors put strain on mitochondria, the cell's energy factories, leading to T cell exhaustion and poor cancer outcomes.

10 Sep 2025

New method reveals how mitochondrial DNA mutations influence cancer growth

Mitochondria act as energy factories in cells and have their own, separate DNA. Mutations to mitochondrial DNA (mtDNA) have been observed in cancer, but it has been unclear how these changes might affect cancer growth.

10 Sep 2025

GABA identified as key blocker of neural repair in spinal cord injury

Spinal cord injuries caused by external trauma, such as traffic accidents or falls, often lead to the permanent loss of motor and sensory functions.

10 Sep 2025

New tool helps identify risky medications for older cancer patients

New research published in the September 2025 issue of JNCCN-Journal of the National Comprehensive Cancer Network validates the use of a specifically-curated tool for determining which medications may be causing harm for older patients with cancer.

10 Sep 2025

Nanobody-based strategy targets survivin to weaken cancer cells

Cancer cells have many strategies for resisting therapy. One such strategy is survivin, a protein that drives the division of diseased cells and prevents them from dying.

10 Sep 2025

Survey shows ongoing misconceptions about hormone therapy safety in cancer survivors

Despite evidence suggesting the safety of hormone therapy for patients with a history of low-grade endometrial or epithelial ovarian cancer, a new survey shows that many gynecologists and some gynecologic oncologists are still uncomfortable prescribing the therapy for this patient population.

10 Sep 2025

New technique used to conduct real-time measurement of boron in live tumor cells

A new technique has measured boron in individual cancer cells for the first time, enabling researchers to better understand how drugs act to kill tumors in some cancers.

10 Sep 2025

Can video game–style exercise slow Alzheimer’s risk?

Gamified exercise training improves hippocampal volume and cognitive performance in mild neurocognitive disorders, offering potential for dementia prevention.

10 Sep 2025

Bottlebrush particles deliver large range of chemotherapy drugs directly to tumor cells

Using tiny particles shaped like bottlebrushes, MIT chemists have found a way to deliver a large range of chemotherapy drugs directly to tumor cells.

10 Sep 2025

Subcutaneous amivantamab plus lazertinib yields high response in EGFR-mutant lung cancer

A new analysis from the PALOMA-2 study presented today shows that subcutaneous administration of amivantamab every four weeks (Q4W), in combination with daily oral lazertinib, yields a high objective response rate in patients with previously untreated EGFR-mutated advanced non-small cell lung cancer (NSCLC).

10 Sep 2025

Ketogenic diet shows promise in reducing depression symptoms in college students

A new study shows an association between at least 10 weeks of following a well-formulated ketogenic diet and a roughly 70% decrease in depression symptoms among a small group of college students.

9 Sep 2025

Experts review the evidence on coenzyme Q10 and cognitive decline

Researchers reviewed evidence on coenzyme Q10 (CoQ10) and cognition, finding strong biological support and positive results in animal models but mixed outcomes in human trials. Larger, high-quality studies are needed to clarify whether CoQ10 can protect against cognitive decline and neurodegenerative diseases.

9 Sep 2025

City of Hope launches innovative national clinical trials model to expand access to cancer treatments

City of Hope, one of the largest and most advanced cancer research and treatment organizations in the U.S., launched an innovative national clinical trials model to expand access to emerging life-saving cancer treatments to more patients across the country.

9 Sep 2025

Biofeedback improves speech in children at a faster rate than traditional methods

Run. Red. World. Pronouncing the "r" sound in these words requires precise control of the tongue. For most children, this happens naturally, but many children struggle with residual speech sound disorder (RSSD) in which speech errors persist past the age of eight.

9 Sep 2025

Abselion launches AAVX and AAV9 Total Capsid Quantification Kits

Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its product offering, with the launch of the AAVX Total Capsid Quantification Kit and the AAV9 Total Capsid Quantification Kit.

9 Sep 2025

New tool can predict where deadly brain cancer might reappear

Glioblastoma is a devastatingly effective brain cancer. Doctors can cut it out or blast it with radiation, but that only buys time. The cancer has an insidious ability to hide enough tumor cells in tissue around the tumor to allow it to return as deadly as ever.

9 Sep 2025

Therapy News and Research

Fitness study shows exercise at work can cut chronic disease risks

Elinzanetant reduces hot flashes in menopause

Antibody cocktail could change the way the world fights influenza

Study highlights menopause-related vocal changes in women

Targeting telomere damage offers new path to boost cancer immunotherapy

New method reveals how mitochondrial DNA mutations influence cancer growth

GABA identified as key blocker of neural repair in spinal cord injury

New tool helps identify risky medications for older cancer patients

Nanobody-based strategy targets survivin to weaken cancer cells

Survey shows ongoing misconceptions about hormone therapy safety in cancer survivors

New technique used to conduct real-time measurement of boron in live tumor cells

Can video game–style exercise slow Alzheimer’s risk?

Bottlebrush particles deliver large range of chemotherapy drugs directly to tumor cells

Subcutaneous amivantamab plus lazertinib yields high response in EGFR-mutant lung cancer

Ketogenic diet shows promise in reducing depression symptoms in college students

Experts review the evidence on coenzyme Q10 and cognitive decline

City of Hope launches innovative national clinical trials model to expand access to cancer treatments

Biofeedback improves speech in children at a faster rate than traditional methods

Abselion launches AAVX and AAV9 Total Capsid Quantification Kits

New tool can predict where deadly brain cancer might reappear

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News